Firalis Molecular Precision is proud to offer a grant program in partnership with Vizgen, which will enable the winner access to a MERSCOPE® Platform single-cell spatial analysis project leveraging the new PanCancer Pathways or PanNeuro Cell Type Panels.

As part of this grant, the winner will not only have access to cutting-edge technology but will also be granted comprehensive data analysis services provided by our highly skilled bioinformatics team.

The Vizgen MERSCOPE® Platform is the first and only commercial solution for MERFISH technology, enabling massively multiplexed, error-robust, single-cell in situ transcriptomic imaging. Due to the complex nature of this technology, it requires specialized expertise to ensure optimal utilization and interpretation of the obtained results. At Firalis Molecular Precision, we have an experimented bioinformatics team in utilizing the MERSCOPE® Platform, allowing us to provide comprehensive data analysis services and extracting meaningful insights from the complex single-cell spatial transcriptomic data.

The fortunate winner of this program will be rewarded with a comprehensive lab service project which entails the utilization of cutting-edge technology, namely the MERFISH measurement technique, coupled with the remarkable MERSCOPE PanCancer Pathways or PanNeuro Cell Type Panels.

• Vizgen’s MERSCOPE® PanCancer Pathways Panel features a curated list of genes targeting canonical signaling pathways of cancer. It enables to characterize tumor behavior at cellular and subcellular levels across multiple different types of cancers.